Blacks Likely to Benefit From Targeted Lung Cancer Therapy:
Links shared publicly online about this topic.
- 840total visits
Blacks Likely to Benefit From Targeted Lung Cancer Therapy:
View full resource at health.msn.com
Tags: Cancer, Lung Cancer, Lung
Most Recently Shared on September 28, 2010 at 9:27 pm By:
Blacks Likely to Benefit From Targeted Lung Cancer Therapy: http://on.msn.com/a0AOeI
Blacks Likely to Benefit From Lung Cancer Therapy - Cancer Information (Cancers, Symptoms, Treatment) on MedicineNet.com
medicinenet.com — “Information on many different cancers includes symptoms, cancer detection and prevention, and treatment options.” View full resource at medicinenet.com
Most Recently Shared on September 30, 2010 at 8:22 am By:
Blacks Likely to Benefit From Targeted Lung Cancer Therapy: Title: Blacks Likely to Benefit From Targeted Lung Can... http://bit.ly/98M2tJ
African-Americans Equally Likely To Benefit From Erlotinib And Other Targeted Lung Cancer Therapy
medicalnewstoday.com — “African-American patients with non-small cell lung cancer are just as likely to display an epidermal growth factor receptor (EGFR) mutation in tumors as Caucasians, which suggests they are as like” View full resource at medicalnewstoday.com
Most Recently Shared on September 29, 2010 at 3:05 pm By:
African-Americans Equally Likely To Benefit From Erlotinib And Other Targeted Lung Cancer Therapy http://mnt.to/3Kv7 #lungcancer
African-Americans equally likely to benefit from erlotinib and other targeted lung cancer therapy
eurekalert.org — “African-American patients with non-small cell lung cancer are just as likely to display an epidermal growth factor receptor mutation in tumors as Caucasians, which suggests they are as likely to benefit from targeted therapies such as erlotinib.” View full resource at eurekalert.org
Most Recently Shared on September 29, 2010 at 2:19 am By:
African-Americans equally likely to benefit from erlotinib and other targeted lung cancer therapy: ( American Asso... http://bit.ly/cEkPNf
African-Americans Equally Likely to Benefit from Erlotinib and Other Targeted Lung Cancer Therapy
newswise.com — “Large study shows equal prevalence of EGFR mutations. EGFR mutations among African-Americans more likely to be found on exon 19, rather than exon 21. Patients with EGFR mutations are more likely to respond to erlotinib.” View full resource at newswise.com
Most Recently Shared on September 29, 2010 at 1:12 am By:
newswise Health Communicator and Health News
African-Americans Equally Likely to Benefit from Erlotinib and Other Targeted Lung Cancer Therapy: * Large study s... http://bit.ly/9hN8TY
Blacks Likely to Benefit From Targeted Lung Cancer Therapy - Drugs.com MedNews
drugs.com — “Despite previous findings to the contrary, new research indicates that black patients with non-small cell lung are as likely to harbor a specific mutation in tu” View full resource at drugs.com
Most Recently Shared on September 28, 2010 at 10:13 pm By:
Drugs and Devices OW OW Health
Blacks Likely to Benefit From Targeted Lung Cancer Therapy: TUESDAY, Sept. 28 -- Despite previous findings to... http://bit.ly/a9ODYx #drug
African-Americans equally likely to benefit from erlotinib and other targeted lung cancer therapy
physorg.com — “African-American patients with non-small cell lung cancer are just as likely to display an epidermal growth factor receptor (EGFR) mutation in tumors as Caucasians, which suggests they are as likely to benefit from targeted therapies such as erlotinib.” View full resource at physorg.com
Most Recently Shared on September 28, 2010 at 8:32 pm By:
PhysOrg Health News Health News
African-Americans equally likely to benefit from erlotinib and other targeted lung cancer therapy http://tw.physorg.com/204910355
Biodesix Announces Issuance Of Key Patent For Serum Test That Identifies Lung Cancer Patients Likely To Benefit From Targeted Therapy
medicalnewstoday.com — “Biodesix, Inc., a company developing and commercializing molecular diagnostics for personalized medicine, announced that the United States Patent and Trademark Office has awarded to the Company p” View full resource at medicalnewstoday.com
Most Recently Shared on June 23, 2010 at 1:05 pm By:
Biodesix Announces Issuance Of Key Patent For Serum Test That Identifies Lung Cancer Patients Likely To Benefit From T... http://mnt.to/3Fdw
Advertisement
